Joerg Willuda
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- Atherosclerosis and Cardiovascular Diseases
- Toxin Mechanisms and Immunotoxins
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
-
- Toxin Mechanisms and Immunotoxins 1
- Atherosclerosis and Cardiovascular Diseases 1
- Co-authors
- Pius August Schubiger (1 shared paper)Robert Waibel (1 shared paper)Rolf Arno Stahel (1 shared paper)Andreas Plückthun (1 shared paper)Annemarie Honegger (1 shared paper)Uwe Zangemeister‐Wittke (1 shared paper)Andreas Menrad (1 shared paper)Eckart Fleck (1 shared paper)
- Journals
- Gene Therapy (1 paper)Translational Oncology (1 paper)Targeted Oncology (1 paper)Neoplasia (1 paper)Atherosclerosis (1 paper)
- Partner nations
- GermanySwitzerlandSingapore
In The Last Decade
Joerg Willuda
7 papers receiving 342 citations
Peers
Comparison fields: 5 of 45
- Radiology, Nuclear Medicine and Imaging 140
- Immunology 80
- Immunology and Allergy 17
- Oncology 37
- Biomaterials 19
Countries citing papers authored by Joerg Willuda
This map shows the geographic impact of Joerg Willuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Willuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Willuda more than expected).
Fields of papers citing papers by Joerg Willuda
This network shows the impact of papers produced by Joerg Willuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Willuda. The network helps show where Joerg Willuda may publish in the future.
Co-authors
The 25 scholars most cited alongside Joerg Willuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. | 1999 | 182 |
| 2 | 2011 | 63 | |
| 3 | 2006 | 35 | |
| 4 | T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction | 2022 | 33 |
| 5 | 2008 | 28 | |
| 6 | 2022 | 18 | |
| 7 | 2008 | 11 | |
| 8 | 2025 | 0 |
About Joerg Willuda
Joerg Willuda is a scholar working on Oncology, Immunology, Biomaterials, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 370 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Toxin Mechanisms and Immunotoxins (1 paper), Axon Guidance and Neuronal Signaling (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Virus-based gene therapy research (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (140 citations), Immunology (80 citations), Immunology and Allergy (17 citations), Oncology (37 citations) and Biomaterials (19 citations). Joerg Willuda has collaborated with scholars based in Germany, Switzerland and Singapore. Frequent co-authors include Pius August Schubiger, Robert Waibel, Rolf Arno Stahel, Andreas Plückthun, Annemarie Honegger, Uwe Zangemeister‐Wittke, Andreas Menrad, Eckart Fleck, Kristof Graf and Kirstin Atrott. Their work appears in journals such as Gene Therapy, Translational Oncology, Targeted Oncology, Neoplasia and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.